Medacta Group SA (OTCPK:MEDGF)
$ 83.91 (0%) Market Cap: 3.44 Bil Enterprise Value: 3.70 Bil PE Ratio: 31.28 PB Ratio: 6.54 GF Score: 91/100

Full Year 2024 Medacta Group SA Earnings Call Transcript

Mar 25, 2025 / 12:00PM GMT
Release Date Price: $83.91

Key Points

Positve
  • Medacta Group SA (XSWX:MOVE) reported a strong revenue growth of over 16% in constant currency, surpassing EUR590 million.
  • The company achieved an excellent profitability with a 28% EBITDA margin in constant currency, marking a 19.4% increase over 2023.
  • Net profit increased by almost 54% to approximately EUR73 million.
  • A proposed dividend of CHF0.69 per share represents an increase of over 25% year-over-year.
  • The company has maintained a strong focus on sustainability, sourcing 100% of electricity from renewable sources and achieving a 44% reduction in greenhouse gas emissions.
Negative
  • The market growth is expected to slow down in 2025, which could impact Medacta's growth projections.
  • There is a potential for price erosion, with approximately a 1% decrease built into the company's model.
  • The integration of the Parcus acquisition may lead to some dilution in margins and incur integration costs.
  • The company's guidance for 2025 includes a slightly lower adjusted EBITDA margin of around 27%, partly due to the Parcus acquisition.
  • Despite strong growth, the company faces increased competition in the anterior hip market from established players.
Operator

Good afternoon. This is the Chorus Call conference operator. Welcome, and thank you for joining the Medacta Group full year 2024 results conference call. (Operator Instructions) At this time, I would like to turn the conference over to Mr. Francesco Siccardi, CEO of Medacta Group.

Please go ahead, sir.

Francesco Siccardi
Medacta Group SA - Chief Executive Officer, Member of the Group Executive Management

Thank you, and good afternoon, everybody. Welcome to Medacta 2024 full year results. I am here with Corrado Farsetta, Medacta's CFO, and we will guide you through the presentation we released this morning. First of all, let's just remember our disclaimers. So the highlights of 2024 started with our revenue release that were already published few weeks ago, a very good growth over 16% in constant currency, surpassing EUR590 million.

And this is combined with a good excellent profitability with a 28% EBITDA margin in constant currency or EUR27.1 million in euro, a good increase of 19.4% over 2023. The net profit as well increased by almost 54%

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot